Clinical Trials
3 trialsNCT07559474 2026-04-30
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
Incyte Corporation
Phase 1 Not yet recruiting
NCT07550634 2026-04-24
Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment
MindRank AI Ltd
Phase 1 Not yet recruiting
NCT01860326 2016-04-28
Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects
Debiopharm International SA
Phase 1 Completed